Details for New Drug Application (NDA): 213065
✉ Email this page to a colleague
NDA 213065 describes ERLOTINIB HYDROCHLORIDE, which is a drug marketed by Accord Hlthcare, Alembic, Apotex, Chartwell Rx, Eugia Pharma, Hetero Labs Ltd V, MSN, Natco Pharma Ltd, Rising, Shilpa, Sun Pharm, Teva Pharms Usa Inc, and Zydus Pharms, and is included in thirteen NDAs. It is available from ten suppliers. Additional details are available on the ERLOTINIB HYDROCHLORIDE profile page.
The generic ingredient in ERLOTINIB HYDROCHLORIDE is erlotinib hydrochloride. There is one drug master file entry for this compound. Ten suppliers are listed for this compound. Additional details are available on the erlotinib hydrochloride profile page.
The generic ingredient in ERLOTINIB HYDROCHLORIDE is erlotinib hydrochloride. There is one drug master file entry for this compound. Ten suppliers are listed for this compound. Additional details are available on the erlotinib hydrochloride profile page.
Summary for 213065
| Tradename: | ERLOTINIB HYDROCHLORIDE |
| Applicant: | Zydus Pharms |
| Ingredient: | erlotinib hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 213065
| Mechanism of Action | Protein Kinase Inhibitors |
Medical Subject Heading (MeSH) Categories for 213065
Suppliers and Packaging for NDA: 213065
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ERLOTINIB HYDROCHLORIDE | erlotinib hydrochloride | TABLET;ORAL | 213065 | ANDA | Zydus Pharmaceuticals USA Inc. | 68382-913 | 68382-913-06 | 30 TABLET in 1 BOTTLE (68382-913-06) |
| ERLOTINIB HYDROCHLORIDE | erlotinib hydrochloride | TABLET;ORAL | 213065 | ANDA | Zydus Pharmaceuticals USA Inc. | 68382-913 | 68382-913-16 | 90 TABLET in 1 BOTTLE (68382-913-16) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 25MG BASE | ||||
| Approval Date: | Apr 16, 2020 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 100MG BASE | ||||
| Approval Date: | Apr 16, 2020 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 150MG BASE | ||||
| Approval Date: | Apr 16, 2020 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
